Ian Grady, MD
Surgery · Redding, CANPI 1215951371
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $16,550 of the $19,757 with a category attached, or 83.8%. GE HealthCare accounts for 76.6% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $12,318 and has fallen 81.1% since, to $2,325 in 2025.
Across 36 payments — averaging $548.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GE HealthCare$15K
- Bard Peripheral Vascular, Inc.$3K
- Davol Inc.$442
- Myriad Genetic Laboratories, Inc.$236
- Focal Therapeutics, Inc.$161
- Baudax Bio Inc.$102
- plus $235 from 5 others
Across 5 payments — averaging $6500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GE HealthCare$33K
What the payments were for
- Consulting fees$16,55084%
- Travel & lodging$2,19511%
- Food & beverage$1,0135%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GE HealthCare | 6 | $15,133 |
| Bard Peripheral Vascular, Inc. | 8 | $3,448 |
| Davol Inc. | 2 | $442 |
| Myriad Genetic Laboratories, Inc. | 10 | $236 |
| Focal Therapeutics, Inc. | 2 | $161 |
| Baudax Bio Inc. | 1 | $102 |
| Leica Microsystems Inc. | 3 | $101 |
| AstraZeneca | 1 | $73 |
| Siemens Medical Solutions USA, Inc. | 1 | $34 |
| Philips North America LLC | 1 | $24 |
| Samsung HME America, Inc. | 1 | $2 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$19,757 in reported general payments places this provider in the 85th percentile of 2,363 surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Anastrozole | 192 | $3,384 |
| Tamoxifen Citrate | 65 | $1,633 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 45 | $446 |
| Ondansetron Hcl | 50 | $179 |
| Cephalexin | 11 | $30 |
Paid to pharmacies, not to this prescriber.
Other surgery in Redding
- Timothy ChuterSan Francisco$8.8M
- Santiago HorganSan Diego$2.8M
- Rock LiuHayward$1.6M
- David LouriePasadena$1.4M
- Andrea PakulaThousand Oaks$1.4M
- Siew-Ming LeeFresno$1.3M
- Beemen KhalilPalo Alto$1.1M
- John LiphamLos Angeles$942K
- Alexander NedopilLodi$682K
- Barry GardinerSan Ramon$602K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.